Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Evaluation of Ureteral Patency in the Post-indigo Carmine Era | Clinical Trials | Clareo Health

Back to search

COMPLETEDPhase 4

Evaluation of Ureteral Patency in the Post-indigo Carmine Era

NCT02677623•Columbia University

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Ureteral Patency

Interventions

Pyridium

Sodium Fluorescein

+2 more

Locations

United States

Locations (1)

Columbia University Medical Center

New York, New York, United States

Key Dates

Start Date

March 1, 2015

Primary Completion Date

August 1, 2016

Completion Date

August 1, 2016

Last Updated

May 30, 2019

Sponsors

Lead Sponsor

Columbia University

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 30, 2019Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions